SHMT2 and bladder transitional cell carcinoma: For mechanism, it is reported that SHMT2 can inhibit the mitochondrial-mediated apoptosis via the intrinsic signaling pathway in BLCA cells, thus promoting the cell viability and progression of BLCA (Zhang et al., 2022).